use of IL-1 inhibitors , recognizing concerns over patient access due to cost. Noting limited supporting data Underscoring the importance of optimal flare management, the Patient Panel emphasized its preference for early intervention given the challenges of engaging a provider in timely manner, including an at-home "medication-in-pocket" strategy for patients who are able to identify the early signs of flare onset. In the absence of "rapid" access to an effective oral medication, the Patient